Manage Account
Change Password
Sign Out
UserName
Profession Email
Profession Email
|
Contraindications
In men, prostate or breast carcinoma. Severe hepatic impairment. Hypercalcaemia, hypercalciuria. Pregnancy.
|
|
Special Precautions
Lactation; CV disorders, renal/hepatic impairment, epilepsy, migraine, DM, conditions aggravated by fluid retention. Children. Monitor hepatic function.
|
|
Adverse Reactions
Fluid and electrolyte retention; psychiatric effects; hypercalcaemia, impaired glucose tolerance. Men: Impotence, gynaecomastia, hirsutism, male-pattern baldness, acne, seborrhoea, oedema, cholestatic jaundice. Women: Amenorrhoea, menstrual irregularities. Children: Premature closure of epiphyses, stops linear growth; virilisation symptoms.
Potentially Fatal: Hepatotoxicity. |
|
Drug Interactions
May enhance effects of antidiabetics, ciclosporin, levothyroxine, warfarin. Resistance to the effects of neuromuscular blockers may occur.
|
|
CIMS Class
|
|
ATC Classification
D11AE01 - metandienone ; Belongs to the class of topical androgen preparations used in the treatment of dermatological diseases.
A14AA03 - metandienone ; Belongs to the class of androstan derivative anabolic steroids used as systemic anabolic agents. |
